
2.30 Delayed Data As of Jan 15 | ![]() Today’s Change | 1.00 Today|||52-Week Range 6.90 | +5.02% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Hepion Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +247.83% increase from the last price of 2.30.
The current consensus among 1 polled investment analysts is to Buy stock in Hepion Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.